Projects per year
Collaborations and top research areas from the last five years
Projects
- 3 Active
-
Innovation of HIV care
van der Valk, M., Moody, K., Mendes de Leon, K., Nieuwkerk, P., Nellen, F. & Bedert, M.
1/05/2022 → …
Project: Research
-
Reiss P.: Complications of HIV and HIV treatment
van den Hof, M., Kooij, K., Langebeek, N., Schouten, J., Su, T., Verboeket, S., Verheij, E., van Zoest, R., Reiss, P., Kootstra, N., van der Valk, M., Wit, F., Verburgh, M., van der Wulp, I. & Vanbellinghen, M.
1/11/2006 → …
Project: Research
-
SHM: epidemiology and clinical course of HIV in the Netherlands and abroad
van der Valk, M., van Sighem, A., Wit, F., Smit, C., Bezemer, D., Boyd, A., Jongen, V. & Popping, S.
1/06/1996 → …
Project: Research
-
Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine
Kooij, K. W., Wit, F. W. N. M., van Zoest, R. A., Schouten, J., Kootstra, N. A., van Vugt, M., Prins, M., Reiss, P. & van der Valk, M., 2016, In: AIDS (London, England). 30, 11, p. 1771-1780Research output: Contribution to journal › Article › Academic › peer-review
30 Citations (Scopus) -
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection
van der Valk, M., Zaaijer, H. L., Kater, A. P. & Schinkel, J., 2017, In: Journal of Hepatology. 66, 1, p. 242-243Research output: Contribution to journal › Comment/Letter to the editor › Academic
61 Citations (Scopus) -
Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life
Willemse, S. B., Baak, L. C., Kuiken, S. D., van der Sluys Veer, A., Lettinga, K. D., van der Meer, J. T. M., Depla, A. C. T. M., Tuynman, H., van Nieuwkerk, C. M. J., Schinkel, C. J., Kwa, D., Reesink, H. W. & van der Valk, M., Dec 2016, In: Journal of viral hepatitis. 23, 12, p. 950-954 5 p.Research output: Contribution to journal › Article › Academic › peer-review
22 Citations (Scopus) -
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study
Nichols, B. E., Boucher, C. A. B., van der Valk, M., Rijnders, B. J. A. & van de Vijver, D. A. M. C., 2016, In: Lancet infectious diseases. 16, 12, p. 1423-1429Research output: Contribution to journal › Article › Academic › peer-review
82 Citations (Scopus) -
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study
AUTHOR GROUP, 2014, In: Clinical Infectious Diseases. 59, 12, p. 1787-1797Research output: Contribution to journal › Article › Academic › peer-review
578 Citations (Scopus)
-
European AIDS Clinical Society (External organisation)
Marc van der Valk (Member)
2021 → …Activity: Membership › Membership of guidelines
-
stichting HEPNED (External organisation)
Marc van der Valk (Member)
2014 → …Activity: Membership › Membership of guidelines
-
stichting HEPNED (External organisation)
Marc van der Valk (Member)
2014 → …Activity: Membership › Membership of guidelines
-
Nederlandse Internisten Vereniging (External organisation)
Marc van der Valk (Member)
2009 → …Activity: Membership › Membership of network › Professional
-
European AIDS Clinical Society (External organisation)
Marc van der Valk (Member)
2009 → …Activity: Membership › Membership of network › Professional